ibrutinib capsules
for oral use Initial U.S. Approval: 2013
Facts about ibrutinib capsules
Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): Ibrutinib
Dosage Forms And Strengths: Capsules: 70 mg and 140 mg
Tablets: 140 mg, 280 mg, 420 mg, and 560 mg
Oral suspension: 70 mg/mL
Companies: AbbVie, Johnson & Johnson
Diseases: Imbruvica is indicated for chronic lymphocytic leukemia (CLL), chronic lymphocytic leukemia (CLL) with 17p deletion, Waldenström’s macroglobulinemia (WM) and mantle cell lymphoma (MCL) who have received at least one prior treatment
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ibrutinib capsules” based on the information you provide.
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.